Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

UNITED STATES: Certara, C-Path Partner on Lung Model for TB Drugs




 

Drug Discovery & Development Magazine (09.11.2013) Aids Weekly Plus

Certara, which provides software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, recently announced a partnership with the Critical Path Institute (C-Path) to develop a physiologically based pharmacokinetic model of the human lung. The model would work in combination with Certara’s Simcyp Population-Based Simulator to determine the disposition of drugs in the lungs and the potential impact of disease-progression on drug kinetics at different stages of TB infection. According to C-Path President and CEO Dr. Martha Brumfield, drug developers could use the model to define dose regimens that would produce clinical concentrations of drugs at specific sites in the lungs and help accelerate development of new TB drugs. The Critical Path to TB Drug Regimens Initiative supports this project.



 


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in September 17, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.